Employees: 1,237
Size Milbon (4919.T) is a Japan Consumer Staples company (Household/Personal Care) with a market value of $743M, the 874th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥3,755 on 18 Nov 2026.
Performance Over six months the shares gained 47.8%, against -12.0% for the median peer and -1.4% for the Japan market (cap-weighted) — 3rd highest of 21 in its peer set.
Growth Revenue grew 7.7% over the last twelve months (peer median +11.5%); the operating margin is 14.1% (peer median 8.8%).
Valuation It trades at 25.7× forward earnings against a peer median of 18.5× (7th most expensive of 20).
Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -11 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 9.2 points above its cost of capital (5.0% WACC).
Next results Next results expected around 12 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥56.2B | ¥52.9B | ¥51.3B | ¥47.8B | ¥45.2B |
| Revenue growth | — | +3% | +7% | +6% | — |
| Gross profit | ¥35.8B | ¥33.2B | ¥32.6B | ¥29.5B | ¥29.5B |
| EBITDA | ¥10.3B | ¥7.75B | ¥9.11B | ¥7.80B | ¥9.63B |
| Net income | ¥5.89B | ¥3.44B | ¥5.02B | ¥4.00B | ¥5.58B |
| Free cash flow | n/a | ¥2.44B | ¥5.43B | ¥2.17B | ¥1.95B |
| Capital expenditure | n/a | ¥3.33B | ¥2.54B | ¥3.21B | ¥3.82B |
| Total debt | ¥0 | ¥0 | ¥0 | ¥0 | ¥0 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 4919.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +10.0% | -9.2% | 2nd highest of 21 |
| 6-month return | +47.8% | -12.0% | 3rd highest of 21 |
| Distance from 52-week high | -2.5% | -38.0% | highest of 21 |
| Revenue growth (TTM) | +7.7% | +11.5% | 9th lowest of 21 |
| Operating margin | 14.1% | 8.8% | 6th highest of 21 |
| Forward P/E | 25.7× | 18.5× | 7th most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | -3.3% | 4.4% | 4th least demanding of 16 |
| Growth delivered (Del g) | +8.2% | +8.9% | 8th lowest of 16 |
| Hurdle (Req g minus delivered) | -11.5 pp | -3.3 pp | 6th least demanding of 16 |
| ROIC minus cost of capital | +9.2 pp | +5.6 pp | 8th highest of 21 |
| EV / EBITDA | 10.4× | 9.8× | 6th cheapest of 11 |
| Net debt / EBITDA | -1.1× | -0.9× | 6th least indebted of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Milbon 4919.T | Japan | $743M | +48% | +8% | 14% | 25.7× | -3.3% | +8.2% |
| Hangzhou Haoyue Personal Care 605009.SS | China | $726M | -18% | +10% | 6% | 17.7× | 4.4% | +7.7% |
| Jyothy Labs JYOTHYLAB.NS | India | $762M | -9% | +5% | 8% | 40.8× | 34.5% | +8.9% |
| SYoung 300740.SZ | China | $816M | -48% | +14% | 3% | 33.4× | 14.0% | +6.1% |
| Galaxy Surfactants GALAXYSURF.NS | India | $845M | +22% | +30% | 9% | 17.6× | 18.5% | +13.7% |
| Cosmecca Korea 241710.KS | South Korea | $847M | +23% | +42% | 12% | 16.3× | n/a | n/a |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $912M | +13% | +10% | 11% | 27.9× | 3.7% | +10.8% |
| Runben Biotechnology 603193.SS | China | $918M | -30% | +13% | 21% | 18.5× | 1.5% | +28.4% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $933M | +56% | +24% | 5% | 52.5× | 28.5% | +0.8% |
| Noevir 4928.T | Japan | $978M | +7% | -3% | 28% | 20.4× | -12.8% | +4.1% |
| Bajaj Consumer Care BAJAJCON.NS | India | $560M | -24% | +29% | 22% | 19.7× | 14.8% | +5.0% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.04B | +15% | +74% | 18% | 11.8× | 11.3% | +49.0% |
| PZ Cussons PZC.L | United Kingdom | $527M | +13% | +5% | 11% | 12.7× | -2.3% | -2.1% |
| d'Alba Global 483650.KS | South Korea | $1.13B | -55% | +49% | 22% | 12.0× | -6.6% | +53.0% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.17B | -42% | +23% | 8% | 14.4× | -6.1% | +21.2% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $454M | -26% | +3% | 4% | n/a | n/a | n/a |
| Tianjin Yiyi Hygiene Products 001206.SZ | China | $429M | -15% | -8% | 9% | 19.9× | 1.9% | +6.3% |
| Edgewell Personal Care EPC | United States | $1.30B | +67% | -10% | 7% | 14.2× | n/a | n/a |
| Lafang China 603630.SS | China | $414M | -19% | +5% | 3% | 37.6× | n/a | n/a |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.35B | +27% | 0% | 3% | 37.3× | 28.8% | +22.8% |
| Jinglv Environment Science & Technology 001230.SZ | China | $392M | -25% | +28% | 11% | 13.9× | n/a | n/a |